IDXX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.2B
+6.6%
1.1B
+4.6%
1.1B
-1.3%
1.1B
-0.4%
1.1B
Cost of Revenue
437.5M
+4.6%
418.1M
-3.3%
432.5M
+2.5%
421.9M
+1.7%
414.7M
Gross Profit
779.1M
+7.8%
722.7M
+9.8%
658.1M
-3.7%
683.4M
-1.6%
694.7M
Operating Expenses
353.5M
-1.8%
360.2M
+5.2%
342.5M
+4.3%
328.5M
+2.1%
321.7M
R&D
65.4M
-0.5%
65.8M
-1.6%
66.8M
+5.4%
63.4M
+2.5%
61.9M
SG&A
288.1M
-2.1%
294.4M
+6.8%
275.7M
+4.0%
265.1M
+2.0%
259.8M
Operating Income
425.6M
+17.4%
362.6M
+14.9%
315.6M
-11.1%
354.8M
-4.9%
373.0M
EBITDA
466.6M
+16.6%
400.3M
+13.0%
354.3M
-9.5%
391.5M
-4.2%
408.8M
Net Income
338.4M
+21.5%
278.4M
+12.2%
248.2M
-9.6%
274.6M
-6.6%
294.0M
EPS (Basic)
$4.29
+22.6%
$3.50
+12.5%
$3.11
-9.3%
$3.43
-6.3%
$3.66
EPS (Diluted)
$4.27
+23.1%
$3.47
+12.7%
$3.08
-9.4%
$3.40
-6.3%
$3.63
Shares (Diluted)
79.3M
-1.1%
80.2M
-0.4%
80.5M
-0.2%
80.7M
-0.4%
81.0M
Idexx Laboratories (IDXX) โ€” Financials